Page last updated: 2024-08-26

fibrinogen and Non-ST Elevated Myocardial Infarction

fibrinogen has been researched along with Non-ST Elevated Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
He, D; Li, Z; Song, J; Sun, Z; Yu, T1
Barth, J; Meister-Langraf, RE; Princip, M; Schmid, JP; Schnyder, U; von Känel, R; Znoj, H1

Other Studies

2 other study(ies) available for fibrinogen and Non-ST Elevated Myocardial Infarction

ArticleYear
Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Coronary artery disease, 2020, Volume: 31, Issue:2

    Topics: Acute Coronary Syndrome; Age Factors; Aged; Angina, Unstable; Blood Pressure; Cohort Studies; Creatinine; Electrocardiography; Female; Fibrinogen; Heart Arrest; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve

2020
Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction.
    BMC cardiovascular disorders, 2018, 11-21, Volume: 18, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Coagulation Factors; Epinephrine; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydrocortisone; Male; Middle Aged; Neurotransmitter Agents; Non-ST Elevated Myocardial Infarction; Norepinephrine; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sleep; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; ST Elevation Myocardial Infarction; von Willebrand Factor

2018